Fatal delays in administering life-saving epinephrine auto-injectors (EAIs), such as EpiPens, are emerging as a major preventable factor in pediatric food-related deaths, according to new research presented at the Royal College of Emergency Medicine Conference. The study highlights a critical gap in pre-hospital management for children suffering from anaphylaxis, a severe and rapidly progressing allergic reaction. With hospital admissions for childhood food allergies surging by 600% over the last two decades, researchers are calling for improved emergency protocols and greater public awareness.
The research reveals a devastating trend: in 74% of fatal cases analyzed, the child either received no epinephrine at all or only a single dose before suffering cardiac arrest. Alarmingly, 37% of the children did not have an EAI with them at the time of the reaction. Experts emphasized that the window for intervention is extremely narrow, with the average time from the first sign of symptoms to cardiac arrest being just 14 minutes. In every case reviewed, cardiac arrest occurred before the child reached an emergency department.
Dr Tom Roberts, a co-author of the study and A&E clinician, underscored the urgency of early treatment. “Our research reveals that in many cases, children did not receive enough [epinephrine] before cardiac arrest, and some didn’t carry an [EAI] at all,” Roberts said. He warned that there is a “very short window of time, often just minutes, in which appropriate treatment can potentially alter the clinical course,” noting that failing to deliver a second dose when needed can have “fatal consequences.”
The study also identified a critical disconnect between current medical guidance and the underlying cause of death in these cases. While many emergency protocols emphasize heart and circulatory failure, the researchers found that airway and breathing complications were the leading cause of death in nearly every case where a cause could be determined. These findings suggest that fatal food anaphylaxis is more strongly driven by respiratory compromise than previously emphasized in standard training.
Dr John Coveney, the study’s lead author from Bristol Children’s Hospital, noted that current NHS guidelines may need updating to reflect these findings. “Our research also found that airway and breathing problems were the most common causes of fatal food-related anaphylaxis in children,” Coveney explained. He added that the current emphasis on circulatory failure may mean some children do not receive the most effective early interventions.
The findings align with international data, including an Australian analysis led by Dr Ben McKenzie, who lost his 15-year-old son to food anaphylaxis. McKenzie said the research “confirms our Australian findings” that fatal cases are often driven by rapid respiratory decline. Adolescents appear to be at particularly high risk, with nearly 90% of fatalities occurring in children aged 10 to 17.
Ultimately, the research reinforces a clear message: epinephrine must be given immediately at the first sign of a severe reaction. To prevent future tragedies, researchers are calling for updated guidance that better reflects the role of respiratory failure, alongside stronger education efforts emphasizing the importance of carrying—and promptly using—EAIs, including administering a second dose when symptoms persist. As food allergy rates continue to rise, timely epinephrine use remains the most critical factor in saving lives.
If your child has food allergies or is allergic to insect venom or an environmental allergen such as latex, DO NOT LET THEM OUT OF THE HOUSE unless they carry two doses of epinephrine and have been trained on how and when to use them. Their life depends on it.
